Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Polycythemia Vera 2Myeloproliferative Disorders 2Lung Neoplasms 2Tuberous Sclerosis 1Smoking 1Renal Insufficiency, Chronic 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Multiple Sclerosis 1Lymphangioleiomyomatosis 1Liver Cirrhosis, Biliary 1Lip Neoplasms 1Irritable Bowel Syndrome 1Inflammatory Bowel Diseases 1Hepatitis 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Gastritis 1Fibrosis 1Exocrine Pancreatic Insufficiency 1Endocrine Gland Neoplasms 1Dyslipidemias 1Diabetes Mellitus 1Cystic Fibrosis 1Crohn Disease 1Chronic Pain 1Chronic Disease 1

Interventions

pembrolizumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Phlebotomy 1Metabolic Flux Analysis 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lip Neoplasms × Phlebotomy × 1 year × Clear all
NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Stanford University

Recruiting
200 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡